Tamer Mohamed, Aspect Biosystems CEO

No­vo-part­nered 3D bio­print­ing biotech gets $70M+ from Cana­di­an gov­ern­ment

As­pect Biosys­tems has re­ceived $72.75 mil­lion in fund­ing from the gov­ern­ments of Cana­da and British Co­lum­bia to ad­vance its pipeline of pre­clin­i­cal 3D-print­ed tis­sue can­di­dates …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.